Could a zapping cap ease autism symptoms? new trial tests brain stimulation in kids

NCT ID NCT04446442

Recruiting now Symptom relief Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a safe, non-invasive brain stimulation technique called tDCS can help reduce certain autism symptoms, like repetitive behaviors and hyperactivity, in children and young adults aged 4 to 17. Researchers will apply a mild electrical current to the cerebellum for 20 minutes and monitor side effects and symptom changes. The trial involves 60 participants and is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transcranial direct current stimulation (tDCS) – a gentle electrical current applied to the scalp over the cerebellum
What this could lead to: If it works, this could point toward a non-drug way to reduce certain autism symptoms like repetitive behaviors and hyperactivity.
What could go wrong: This is an early, small study (60 people) focused on safety first. It may not show clear symptom improvement, and effects may vary widely among participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER

Contacts and locations

Locations

Children's Medical Center
RECRUITING

Dallas, Texas, 75235, United States
University of Texas Southwestern
RECRUITING

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.